BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
+39.76%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$2.54B
AUM Growth
+$2.54B
(+38%)
Cap. Flow
-$14.3M
Cap. Flow
% of AUM
-0.56%
Top 10 Holdings %
Top 10 Hldgs %
54.04%
Holding
74
New
12
Increased
15
Reduced
24
Closed
6
Top Buys
| 1 |
Olema Pharmaceuticals
OLMA
|
$320M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$47.2M |
| 3 |
4D Molecular Therapeutics
FDMT
|
$45.8M |
| 4 |
Protagonist Therapeutics
PTGX
|
$38.3M |
| 5 |
Lexicon Pharmaceuticals
LXRX
|
$37.5M |
Top Sells
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$164M |
| 2 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$119M |
| 3 |
Celldex Therapeutics
CLDX
|
$45.5M |
| 4 |
Eledon Pharmaceuticals
ELDN
|
$42.4M |
| 5 |
Replimune Group
REPL
|
$38.9M |
Sector Composition
| 1 | Healthcare | 98.24% |
| 2 | Financials | 0.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBIO
26
Crescent Biopharma, Inc. Common Stock
CBIO
$190M
| $35.9M | 1.41% |
9,544,262
+2,300,000
| +32% | +$8.65M |
|
27
Forte Biosciences
FBRX
$137M
| $26.2M | 1.03% |
718,788
-58,765
| -8% | -$2.14M |
|
|
CALT
28
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
| $25.5M | 1% |
750,000
| – | – |
|
29
Verastem
VSTM
$567M
| $23.8M | 0.94% |
11,180,994
+433,000
| +4% | +$922K |
|
30
Immunovant
IMVT
$2.63B
| $23.8M | 0.93% |
514,370
-684,057
| -57% | -$31.6M |
|
|
CTIC
31
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $22.3M | 0.88% |
6,929,690
| – | – |
|
|
CALA
32
DELISTED
Calithera Biosciences, Inc
CALA
| $21.4M | 0.84% |
4,361,238
-224,400
| -5% | -$1.1M |
|
|
MTEM
33
DELISTED
Molecular Templates, Inc.
MTEM
| $20.2M | 0.79% |
2,149,057
| – | – |
|
34
Syndax Pharmaceuticals
SNDX
$1.39B
| $19.5M | 0.77% |
878,524
-1,592,154
| -64% | -$35.4M |
|
35
argenx
ARGX
$43.2B
| $18.4M | 0.72% |
62,491
-107,109
| -63% | -$31.5M |
|
|
FPRX
36
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $17.7M | 0.7% |
1,038,678
-6,970,675
| -87% | -$119M |
|
37
Cogent Biosciences
COGT
$1.68B
| $17.2M | 0.68% |
+1,532,282
| New | +$17.2M |
|
|
PVLA
38
Palvella Therapeutics, Inc. Common Stock
PVLA
$583M
| $13.7M | 0.54% |
5,494,582
| – | – |
|
|
PNT
39
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $13.3M | 0.52% |
954,996
-45,004
| -5% | -$628K |
|
|
40
Eledon Pharmaceuticals
ELDN
$153M
| $11.8M | 0.46% |
763,279
-2,752,594
| -78% | -$42.4M |
|
|
GMDA
41
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $11.3M | 0.44% |
1,343,667
-800,000
| -37% | -$6.71M |
|
42
MEI Pharma
MEIP
$159M
| $10.7M | 0.42% |
4,049,162
-31,000
| -0.8% | -$81.8K |
|
|
GRTS
43
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $10.6M | 0.42% |
+2,695,418
| New | +$10.6M |
|
44
Ovid Therapeutics
OVID
$87.5M
| $10.4M | 0.41% |
4,522,051
+900,000
| +25% | +$2.08M |
|
45
Cartesian Therapeutics
RNAC
$256M
| $10M | 0.39% |
3,304,963
-5,154,584
| -61% | -$15.6M |
|
|
GNCA
46
DELISTED
Genocea Biosciences, Inc.
GNCA
| $9.71M | 0.38% |
4,012,404
| – | – |
|
47
Tango Therapeutics
TNGX
$741M
| $9.15M | 0.36% |
800,000
| – | – |
|
|
CFRX
48
DELISTED
ContraFect Corporation
CFRX
| $8.08M | 0.32% |
1,600,000
| – | – |
|
49
Cidara Therapeutics
CDTX
$1.62B
| $7.48M | 0.29% |
3,739,704
-27,000
| -0.7% | -$54K |
|
50
Corvus Pharmaceuticals
CRVS
$422M
| $6.92M | 0.27% |
1,943,712
+200,000
| +11% | +$712K |
|